Veterinary Medicines

Primucell FIP

Authorised
  • Feline coronavirus, strain DF2-ts, Live
Download as PDF

Product identification

Medicine name:
Primucell FIP
Active substance:
  • Feline coronavirus, strain DF2-ts, Live
Target species:
  • Cat
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Feline coronavirus, strain DF2-ts, Live
    25118900.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 426a/91
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 19/04/2022
Download